Nanostics Inc Patents

Patent portfolio assigned to Nanostics Inc (verified via public assignee records). Edmonton, Canada (University of Alberta spinout) liquid-biopsy cancer diagnostics; lead product ClarityDX Prostate. Partners: Protean BioDiagnostics (US distribution), OncoHelix (Middle East distribution, via lab with Burjeel Holdings in Abu Dhabi), University of Alberta (Innovation Fund). Google Patents page CA3003032A1 'Methods of diagnosing disease using microflow cytometry' covers the company's core technology; exact assignee field could not be fetched (Google Patents blocked automated access) but multiple sources tie the patent to Nanostics, so has_patents=true. Note customers listed are distribution/commercial partners, not disclosed paying end-customers.